Light Treatment of Vaginal Infections in Reproductive Age Women

NCT06985433 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2026-02-17

No results posted yet for this study

Summary

Antimicrobials have helped in managing vaginal dysbiotic conditions such as bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC). However, their increasing inefficiency and rise in antimicrobial resistance (AMR) is a challenge and threat to public health. Therefore, this study will investigate the safety and efficacy of light as an antimicrobial to treat vulvovaginal infections.

Conditions

  • Bacterial Vaginosis
  • Vulvovaginal Candidiases

Interventions

DEVICE

Vaginal Light Therapy - Once

Vaginal light therapy device will deliver UVA and blue light to target symptom causing microbes in single treatment session.

DEVICE

Vaginal Light Therapy - Twice

Vaginal light therapy device will deliver UVA and blue light to target symptom causing microbes in two treatment sessions.

DEVICE

Vaginal Light Therapy - Twice

Vaginal light therapy device will deliver UVA and blue light to target symptom causing microbes in two treatment sessions.

DEVICE

Vaginal light therapy - Once

Vaginal light therapy device will deliver UVA and blue light to target symptom causing microbes in single treatment session.

Sponsors & Collaborators

  • Odense University Hospital

    collaborator OTHER
  • UVISA Health ApS

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-05
Primary Completion
2025-12-29
Completion
2026-02-02

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06985433 on ClinicalTrials.gov